Search

everythinglearnresearchcommunity

for

Search:↓

Red dots on the upper chest may be an early sign of certain types of hair loss.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Diagnosing and treating skin conditions is challenging, especially when drug reactions mimic other diseases.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Naltrexone shows promise as a safe treatment for a type of hair loss called lichen planopilaris.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Hair transplant destroyed by lichen planopilaris.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Linear lichen planopilaris can affect the trunk, not just the face.

Trichoscopy helps diagnose hair and scalp disorders in dark-skinned people by identifying unique patterns.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.